Watson announces post-Actavis merger global generics management team
This article was originally published in Scrip
Executive Summary
Watson has named the members of its global generics management team following the completion of its acquisition of Actavis (scripintelligence.com, 16 October 2012), which has created a generics company with anticipated combined 2012 revenues of over $8 billion.